Current and Upcoming Lung Cancer Research

Video
Conference|American Society of Clinical Oncology Annual Meeting (ASCO)

Dr. Ramaswamy Govindan, Washington U at St. Louis, discusses patient screening, new research in targeted therapies, as well as the continued role of traditional chemotherapy in lung cancer.

Developments in Non-Small-Cell Lung Cancer
Ramaswami Govindan, MD discusses new treatments and developments in the treatment of non-small-cell lung cancer.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Dr. Ramaswamy Govindan, Washington U at St. Louis, discusses patient screening, new research in targeted therapies, as well as the continued role of traditional chemotherapy in lung cancer.

      Recent Videos
      Future of HER2-Directed Tumor-Agnostic Therapies
      Future of HER2-Directed Tumor-Agnostic Therapies
      Influence of DESTINY-PanTumor02 Trials on Trastuzumab Deruxtecan Usage
      Influence of DESTINY-PanTumor02 Trials on Trastuzumab Deruxtecan Usage
      Review of Current Landscape of HER2-Directed Tumor-Agnostic Therapies
      Review of Current Landscape of HER2-Directed Tumor-Agnostic Therapies
      Updates and Clinical Implications of DESTINY-Lung02 and DESTINY-Lung03 Trials
      Updates and Clinical Implications of DESTINY-Lung02 and DESTINY-Lung03 Trials
      HER2 Key Differences and Current Approaches to Biomarker Testing
      HER2 Key Differences and Current Approaches to Biomarker Testing
      Introduction to HER2-Directed Tumor-Agnostic Approaches
      Introduction to HER2-Directed Tumor-Agnostic Approaches
      The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
      Lung Cancer Home Health Screening Tools May Aid in Triaging LDCT+ Patients
      An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
      Cell-Free DNA Assay Achieves High Negative Predicative Value in Lung Cancer
      Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
      Blood Testing for Lung Cancer May Address Inadequate Screening Utilization
      Advocacy groups such as Cancer Support Community and the Leukemia & Lymphoma Society may help support patients with CML undergoing treatment.
      Advocate Outlines Resources for Chronic Myeloid Leukemia Population
      Related Content
      A stronger commitment to tobacco control at the local, state, and federal levels may further improve progress in preventing smoking-related mortality.

      Tobacco Control Helps Avert Millions of Lung Cancer Deaths

      Russ Conroy
      March 27th 2025
      Article

      A stronger commitment to tobacco control at the local, state, and federal levels may further improve progress in preventing smoking-related mortality.

      Georgios Evangelou, MD, MSc, speaks to the potential utility of neoadjuvant capecitabine/temozolomide in well-differentiated atypical carcinoids.

      Exploring the Value of Preoperative CAPTEM in Atypical Lung NETs

      Georgios Evangelou, MD, MSc
      September 16th 2024
      Podcast

      Georgios Evangelou, MD, MSc, speaks to the potential utility of neoadjuvant capecitabine/temozolomide in well-differentiated atypical carcinoids.

      AI/ML-Based Software Improves Diagnostic Accuracy in Lung Cancer

      AI/ML-Based Software Improves Diagnostic Accuracy in Lung Cancer

      Tim Cortese
      February 5th 2025
      Article

      The diagnostic accuracy of radiologists aided by the eyonis LCS AI software was greatly improved compared with when radiologists were unaided.

      Neil M. Iyengar, MD, and Paolo Tarantino, MD, discuss updated data on agents such as T-DXd and abemaciclib in breast cancer presented at 2024 ASCO.

      Applying Updated Breast Cancer Findings From ASCO to Clinical Practice

      Neil M. Iyengar, MD;Paolo Tarantino, MD
      June 17th 2024
      Podcast

      Neil M. Iyengar, MD, and Paolo Tarantino, MD, discuss updated data on agents such as T-DXd and abemaciclib in breast cancer presented at 2024 ASCO.

      The mean number of palliative care visits was nearly halved for stepped-palliative care vs early palliative care in patients with advanced lung cancer.

      Stepped Care Model for Lung Cancer May Maintain QOL With Fewer Visits

      Roman Fabbricatore
      August 6th 2024
      Article

      The mean number of palliative care visits was nearly halved for stepped-palliative care vs early palliative care in patients with advanced lung cancer.

      Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs

      Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs

      Georgios Evangelou, MD, MSc;Ioannis Vamvakaris, MD, PhD, MSc;Irene Konstantopoulou, PhD;Konstantinos Syrigos, PhD
      July 10th 2024
      Article

      Read about a woman with well-differentiated atypical carcinoid who experienced a 21% regression in primary tumor size after 12 months on neoadjuvant capecitabine and temozolomide.